(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3(Date:10/6/2008)... polyphenol-rich 100% Concord grape,juice was not ... or body,weight, CONCORD, Mass., Oct. 6 /PRNewswi... Concord grape juice did not cause significant wei...ite and was shown to reduce waist,circumference ac...eeting of,the American College of Nutrition in Arl...
(Date:10/3/2008)...nhibitors for Cancer Treatments, INDIANAPOLIS, In...l/ --,Eli Lilly and Company (NYSE: LLY ) and priv...nounced that the two companies have entered,into a...elated to,Deciphera,s preclinical B-Raf kinase inh... therapeutics., The collaboration will apply Deci...
(Date:10/2/2008)...wire/ -- Calabar AB announced today,that their Pha...h"),patients has been initiated. Specifically, the...ween the ages of 20 to 75. The objective of the st...ding Phase III efficacy,study., Xalieve(TM) is a ...tigmine. It is administered locally in the mouth w...
(Date:10/1/2008)...of Amylin,s integrated neurohormonal ...O, Oct. 1 /- Amylin Pharmac...at new data for its pipeline obesity,candidates wi...ing of The,Obesity Society in Phoenix October 3-7....e largest and most comprehensive scientific confer...
Breaking Medicine Technology:Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 569 1American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 569 2American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 569 3Tooth Troubles Could Raise Dementia Risk 4081 1Meeting real world climate information needs of business government 883 1Meeting real world climate information needs of business government 883 2Capsugels Liquid Dosage Form Technology Utilized by Eight of the Top 10 Pharmaceutical Companies 4076 1Capsugels Liquid Dosage Form Technology Utilized by Eight of the Top 10 Pharmaceutical Companies 4076 2...July 06, 2007 /PRNewswire-FirstCall/ --,Genzyme Co...f two,Phase 3 clinical studies to assess the safet...onal, non-antibiotic, polymer,therapy for patients...DAD). The second Phase 3 study of tolevamer liquid...this year. , In this first Phase 3 study known as ...
...ESS WIRE)--Jul 9, 2007 - TransPharma Medical,Ltd.,... development,and commercialization of drug product...delivery technology, announced today,promising res...the,safety and pharmacokinetic profile of its ViaD...porosis., A seven day, repeated dose application, ...
Other Medicine Technology:Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates.
Bagolini's striated lenses consists of 2 circular lenses in a metal frame with tabs for use by the examiner.
BD Visitec IOL Manipulator, blunt tip, formed 10.0mm from end. Fits 0.20mm diameter holes & larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge indicating positio
BD Visitec™ button tip manipulator, 0.50 mm diameter button tip angled 45, 15.0 mm from end (3/bx, 1 bx/ca). May be used for IOL manipulation or iris retraction. Sterile.
Medicine Products: